Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-21
DOI
10.1038/s41598-018-21923-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart
- (2016) Shigeru Miyagawa et al. CURRENT GENE THERAPY
- Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes
- (2016) Shunsuke Funakoshi et al. Scientific Reports
- Functional and Electrical Integration of Induced Phiripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart
- (2015) Takahiro Higuchi et al. CELL TRANSPLANTATION
- A New Class of Pluripotent Stem Cell Cytotoxic Small Molecules
- (2014) Mark Richards et al. PLoS One
- A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
- (2014) Masato Nakagawa et al. Scientific Reports
- Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen
- (2013) Uri Ben-David et al. Cell Stem Cell
- Enhanced Survival of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by the Combination of Cell Sheets With the Pedicled Omental Flap Technique in a Porcine Heart
- (2013) M. Kawamura et al. CIRCULATION
- Inhibition of pluripotent stem cell-derived teratoma formation by small molecules
- (2013) M.-O. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells
- (2013) Uri Ben-David et al. Nature Communications
- Optimized Surface Markers for the Prospective Isolation of High-Quality hiPSCs using Flow Cytometry Selection
- (2013) Ramzey Abujarour et al. Scientific Reports
- Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
- (2012) Shugo Tohyama et al. Cell Stem Cell
- Highly Sensitive In Vitro Methods for Detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human iPS Cells
- (2012) Takuya Kuroda et al. PLoS One
- Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
- (2012) Alejandro Vazquez-Martin et al. Scientific Reports
- CD30: an important new target in hematologic malignancies
- (2011) Yehuda E. Deutsch et al. LEUKEMIA & LYMPHOMA
- An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells
- (2011) Chad Tang et al. NATURE BIOTECHNOLOGY
- Cardiac tumorgenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction
- (2011) Rafeeq PH Ahmed et al. Regenerative Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started